Pancreatic cancer

Pancreatic cancer is one of the most dangerous forms of gastrointestinal cancer, as its early symptoms are often mild and non-specific, making the disease difficult to detect. Pancreatic cancer often develops rapidly and remains hidden until late stages, when treatment options are already limited. Various factors may influence the risk of developing pancreatic cancer, including genetics, lifestyle, and chronic diseases. Awareness of risk factors and symptoms is important for the prevention and early detection of the disease.

What is pancreatic cancer?

Pancreatic cancer is a malignant tumor that develops in the tissues of the pancreas. The pancreas is an important organ located in the abdominal cavity that performs several vital functions. It produces enzymes and hormones necessary for digestion, including insulin, which regulates blood sugar levels. Pancreatic cancer can affect both the exocrine and endocrine parts, depending on the region where the tumor develops.

This disease is characterized by rapid spread and the absence of early symptoms. Pancreatic cancer often goes unnoticed because there may be no clear signs in the early stages. When symptoms do appear, they can be non-specific, such as abdominal pain, weight loss, or indigestion. Such vagueness of symptoms makes early diagnosis and the initiation of treatment difficult.

Pancreatic cancer is divided into several subtypes, the most common of which is adenocarcinoma. It develops in the exocrine part of the pancreas, which is responsible for producing digestive enzymes. Less common are neuroendocrine tumors, which affect hormone production. Each subtype requires a different approach to diagnosis and treatment.

Risk factors for pancreatic cancer

Several factors influence the likelihood of developing pancreatic cancer. Some of these are related to genetics and heredity, while others are linked to lifestyle and chronic diseases. Understanding risk factors helps raise awareness and direct attention to preventive measures.

Genetic and hereditary factors

Genetic predisposition plays an important role in the development of pancreatic cancer. People with a family history of pancreatic cancer have a higher risk of developing the disease. Specific inherited genetic mutations, such as the BRCA1 and BRCA2 genes (which are linked Breast cancer and ovarian cancer), as well as gene mutations such as CDKN2A and STK11, have been linked to an increased risk of pancreatic cancer. Familial cancers, where family members have been diagnosed with different types of cancer, may indicate a higher genetic predisposition that increases the likelihood of developing pancreatic cancer.

Lifestyle-related risks

The risk of developing pancreatic cancer is closely linked to lifestyle, especially smoking and excessive alcohol consumption. Smoking is one of the main risks, as studies have shown that smokers have a 1.74 times higher risk of pancreatic cancer compared to non-smokers. The highest risk occurs in those who smoke more than 35 cigarettes a day, with their probability of developing pancreatic cancer being even three times higher. Upon quitting smoking, the risk returns over the years to a level similar to that of non-smokers (Klein, 2021).

Furthermore, excessive alcohol consumption is linked to an increased risk of pancreatic cancer. Studies have found that alcohol consumption exceeding 30 g per day increases the risk by up to 1.45 times. Exceptional alcohol consumption can also lead to the development of pancreatitis, which in turn is a known risk factor for pancreatic cancer (Klein, 2021).

Chronic diseases

Chronic diseases, such as diabetes and chronic pancreatitis, can increase the risk of pancreatic cancer. Type II diabetes, in particular, is associated with an increased risk of developing pancreatic cancer because it affects metabolism and promotes chronic inflammation. Likewise, chronic pancreatitis, which causes long-term inflammation in the pancreas, is a proven risk factor for the development of pancreatic cancer. These conditions can damage pancreatic tissue, making it more susceptible to malignant changes.

Symptoms of pancreatic cancer

Symptoms of pancreatic cancer can be mild and non-specific at first, which is why the disease often goes undiagnosed in its early stages. The severity and nature of the symptoms depend on the location, size, and spread of the tumor.

One of the most common symptoms is abdominal pain, which can radiate to the back. The pain often intensifies after eating or when lying down. Weight loss and loss of appetite are also common signs, as the tumor can interfere with digestion and nutrient absorption. In addition, nausea and vomiting may occur, indicating gastrointestinal problems.

When the pancreas is blocked by a tumor, it can cause bile duct obstruction, leading to jaundice. This results in yellowing of the skin and whites of the eyes, and there may also be itching and dark urine. Since pancreatic cancer tends to spread early to the lymph nodes and other organs, other symptoms may also appear, such as abdominal pain,
abdominal bulging, fluid accumulation in the abdomen, or breathing difficulties.

Preventive measures

Prevention of pancreatic cancer begins with following a healthy lifestyle. Although not all risk factors can be controlled, there are several measures that help reduce the likelihood of developing the disease.

Healthy lifestyle

To prevent pancreatic cancer, it is important to follow a healthy lifestyle. One of the main steps is quitting smoking, as this helps reduce the risk of many diseases, including pancreatic cancer. It is also recommended to limit alcohol consumption, as excessive drinking can impair pancreatic function and increase the risk of developing the disease.

Additionally, it is useful to maintain a healthy body weight and pay attention to regular physical activity. A healthy diet aimed at ensuring the balance of necessary nutrients can also be part of general healthcare. All these steps help strengthen the immune system and keep body functions in balance, supporting the effectiveness of preventive measures.

Management of chronic diseases

Regular monitoring of chronic diseases, such as diabetes and chronic pancreatitis, is important for maintaining pancreatic health. Timely treatment and disease control can reduce complications that may increase the risk of pancreatic cancer. Regular doctor visits, monitoring health changes, and following recommended treatment regimens help keep the disease progression under control, thereby being a part of maintaining a healthy lifestyle.

Diagnosis of pancreatic cancer

Diagnosing pancreatic cancer usually begins with a medical consultation where the doctor examines the patient's symptoms and health condition. Initial tests may include blood tests to evaluate organ function and detect potential abnormalities. In the case of pancreatic cancer, blood tests may show, for example, elevated levels of tumor markers such as CA 19-9, although this cannot be used to confirm a diagnosis, as elevated levels also occur in other diseases.

For more thorough investigation, imaging methods such as computed tomography (CT) and magnetic resonance imaging (MRI) are usually used. These methods allow doctors to see the structure of the pancreas and detect the presence, size, and location of a tumor. If a tumor is suspected based on the images, a biopsy is often performed, where a small part of the tumor is removed and sent to the laboratory for examination. The biopsy helps confirm whether it is pancreatic cancer or another disease, allowing doctors to determine an appropriate treatment plan.

Advances in cancer tests have significantly improved the possibilities for early cancer detection, offering additional benefits compared to traditional screening methods. Various tests can now detect multiple cancer types simultaneously using a simple blood test, which can uncover tumors that would remain unnoticed by conventional diagnostic technologies. This allows doctors to identify diseases at an early stage, which in turn increases the likelihood of treatment success and survival.

Some cancer tests focus on the analysis of circulating tumor cells (CTC), which makes it possible to determine the origin of the tumor, such as the tissue or organ from which these cells come. This provides an opportunity to narrow down the choice of further examinations and reduce the risk of false-positive or false-negative results, as the accuracy of the tests is higher than that of traditional methods. High-tech cancer detection methods thus offer additional reliability and help quickly identify cancer in its early, often asymptomatic stages.

Pancreatic cancer is a serious disease for which it is important to monitor all risk factors, including genetic predispositions, lifestyle factors such as smoking and excessive alcohol consumption, and the impact of chronic diseases. The difficulty of early diagnosis makes the prevention and early detection of the disease particularly important. A healthy lifestyle and the control of chronic diseases are essential steps in reducing the risk of pancreatic cancer. Timely medical intervention and the regular use of cancer screening tests help detect the disease early and improve the chances of successful treatment.

Trucheck offers high-level Cancer Diagnosis solution

Our Trucheck cancer tests focus on early detection and supporting personalized treatment, using the latest science and technology.

Based on scientific and clinical evidence

More than 40,000 patients have participated in the validation, accreditation and continuous improvement of the method.

High Quality Standards

All tests are performed in accredited laboratories (CAP, CLIA, TÜV SÜD, etc.) using modern technologies and qualified specialists to ensure accuracy, safety and a high standard of service.
Trucheck
1
Years experience
image-11
A NEW LEVEL IN CANCER RESEARCH

Why noninvasive diagnostics?

Innovative blood-based tests offer a non-invasive approach to cancer detection using a simple blood sample.

Early and Accurate Detection

Trucheck™ is designed to detect circulating tumor cells (CTCs), including in the early stages of cancer.

Early and Accurate Detection

Trucheck™ is designed to detect circulating tumor cells (CTCs), including in the early stages of cancer.

Painless and Quick Tests

The test requires only a blood sample, without the need for an invasive tissue biopsy as part of the testing procedure.

Painless and Quick Tests

The test requires only a blood sample, without the need for an invasive tissue biopsy as part of the testing procedure.

A Personalized Approach

We help you understand your test results and, if necessary, discuss the appropriate next steps.

A Personalized Approach

We help you understand your test results and, if necessary, discuss the appropriate next steps.
Innovative Approaches to Cancer Detection

Non-invasive liquid biopsy tests

Blood or body fluid-based tests that allow early cancer detection without the need for tissue biopsies.

Trucheck Intelli

Intelli is one of the few tests that can detect more than 70 types of cancer.
€1890 / SERVICE
  • For men and women aged 40 and over
  • No prior cancer diagnosis
The service price includes the test, interpretation of the results, and, if necessary, recommendations for further examinations and treatment planning.

Trucheck FemmeSafe

The test detects breast, ovarian, cervical, and uterine cancer early using CTCs.
€1690 / SERVICE
  • For women aged 40 and over
  • No prior cancer diagnosis
The service price includes the test, interpretation of the results, and, if necessary, recommendations for further examinations and treatment planning.
FAQ

Frequently Asked Questions

We have gathered some frequently asked questions that customers have regarding our services.

What are the benefits of the Trucheck analysis?

Trucheck requires only a simple blood test and makes it possible to detect cancers that standard diagnostics often miss. Unlike screenings performed for one cancer type at a time, Trucheck can detect multiple cancer types simultaneously. Early detection is associated with a higher successful treatment rate, offering patients better treatment options and earlier intervention.

What are the risks of the Trucheck analysis?

Knowing about an increased risk or cancer itself, even if it is in an early stage, can have a significant psychological impact on the patient. Patients should be aware that they still need to undergo regular screening according to established guidelines, as Trucheck is not intended to replace routine cancer screening.

Does the Trucheck test have an age limit?

Trucheck is recommended for individuals aged 40–70, but it can also be considered for those aged 35–40 if risk factors are present, such as a family history of cancer, inherited mutations, obesity, diabetes, certain viral infections, or exposure to carcinogens. For more detailed information, please contact the chatbot on the page.

Does Trucheck replace cancer screening?

Hey, Trucheck is not meant to replace screenings. It is an additional cancer test that can be done alongside routine health checks and screenings. It helps detect possible signs of cancer at an early stage, but does not replace regular examinations recommended by a doctor.

Who are the Trucheck tests recommended for?

Trucheck is recommended for individuals with a family history of cancer, or those who wish to add the test to their annual health check-up. It is also suitable for individuals aged 40-70 with a high risk of cancer, who have never been diagnosed with cancer and have no current suspicion of cancer.

 

Who are Trucheck tests not recommended for?

Trucheck is not suitable for people who have had malignant diseases, lymphoma, leukemia, polycythemia, or multiple myeloma. It should also not be performed on pregnant women, those who have received a blood transfusion in the last 10 days, or those with immunodeficiency, such as HIV. For additional information, please contact the chatbot found on the page.

What is the accuracy of Trucheck tests?

Sensitivity 65–891 TP3T

Sensitivity is the ability of a test to correctly identify individuals who have cancer.

Specificity 96% – 99%

Specificity is the ability of a test to correctly identify individuals who do not have cancer.

How long is the waiting time to get the results?

The average waiting time is variably 2-3 weeks.

Order now

Select the blood test service provider